Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
about
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potentialCK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2).Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.Casein kinase: the triple meaning of a misnomer.Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance.Casein kinases as potential therapeutic targets.Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain.Specific inhibition of CK2α from an anchor outside the active siteDifferent Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB.Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis.Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives.Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
P2860
Q27688944-58111419-43E2-440D-A897-28B349BD47D3Q30277146-EC5D31A4-4EA3-43E3-8544-C991B8579B47Q34381851-718550C6-4074-40FA-978E-F14D01039004Q35106800-9601E875-69B3-48DC-8779-5F712BDA3AB4Q37731326-6D0CC4FC-6E0F-4F3C-9C85-4EE1AFB68BBEQ38211598-BF4C7ECA-A517-46EB-910A-F29FE757D5DAQ38492153-0B839ED7-8768-40B4-AAB0-7CAB807BA54BQ38628538-2CAB38FF-4C03-4526-B350-DD2AD4A3FB89Q38632634-2DE36C4B-07AE-4138-B343-6E3304A1F143Q38777113-1BE791B9-570F-4DC0-AE79-92589084C95DQ38815725-4840D55F-F8D2-4CFA-88AF-A5DDC61BD0FAQ38820266-E0D00ACA-54F5-41D4-92E2-06637AA92795Q40189553-DD8F2786-3B57-421F-9381-FD87F1B2A664Q41134308-A2A19583-65D3-4CE9-8AF1-A46E11B54DA4Q42412981-29FB4B46-2867-4FBC-9AF8-9E60CF9F45C5
P2860
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@ast
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@en
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@nl
type
label
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@ast
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@en
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@nl
prefLabel
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@ast
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@en
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@nl
P2093
P2860
P50
P1433
P1476
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells
@en
P2093
Cristina Girardi
Sean E O'Brien
Yoshihiko Miyata
P2860
P304
P356
10.1371/JOURNAL.PONE.0049193
P407
P577
2012-01-01T00:00:00Z